Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-11

Clinical Trial Update: Low Dose of Norepinephrine Within 24-Hour Mortality in Traumatic Patient With Hemorrhagic Shock [NA]

View source ↗

Summary

A completed clinical trial from Tanta University evaluated the impact of low-dose norepinephrine within 24 hours on mortality in patients with traumatic hemorrh…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NOREPINEPHRINE (NOREPINEPHRINE BITARTRATE)

Snippet

Sponsor: Tanta University | Conditions: Mortality Rate, Hemorrhagic Shock | NA | Status: COMPLETED